HTLV seroprevalence in people using HIV pre-exposure prophylaxis in England

Daniel Bradshaw; Arham Khawar; Poorvi Patel; Jennifer Tosswill; Colin Brown; Dana Ogaz; Emily Mason; Roeann Osman; Holly Mitchell; Olamide Dosekun; Borja Mora Peris; Graham Pickard; Michael Rayment; Rachael Jones; Mark Hopkins; Andy Williams; Margaret Kingston; Nicholas Machin; Yusri Taha; Sarah Duncan; Neil Turner; Noel Gill; Nick Andrews; Mohammad Raza; Simon Tazzyman; Achyuta Nori; Emma Cunningham; Graham P. Taylor

doi:10.1016/j.jinf.2023.01.033

HTLV seroprevalence in people using HIV pre-exposure prophylaxis in England

Daniel Bradshaw^*
, Arham Khawar
, Poorvi Patel
, Jennifer Tosswill
, Colin Brown
, Dana Ogaz
, Emily Mason
, Roeann Osman
, Holly Mitchell
, Olamide Dosekun
, Borja Mora Peris
, Graham Pickard
, Michael Rayment
, Rachael Jones
, Mark Hopkins
, Andy Williams
, Margaret Kingston
, Nicholas Machin
, Yusri Taha
, Sarah Duncan

Neil Turner, Noel Gill, Nick Andrews, Mohammad Raza, Simon Tazzyman, Achyuta Nori, Emma Cunningham, Graham P. Taylor

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Abstract

Objectives: HTLV-1 is predominantly a sexually-transmitted infection but testing is not mentioned in HIV-PrEP guidelines. We ascertained HTLV-1/HTLV-2 seroprevalence amongst HIV-PrEP users in England. Methods: An unlinked anonymous seroprevalence study. Results: Amongst 2015 HIV-PrEP users, 95% were men, 76% of white ethnicity and 83% had been born in Europe. There were no HTLV-1/HTLV-2 seropositive cases (95% confidence interval 0% – 0.18%). Conclusions: There were no HTLV positive cases, likely reflecting the demographic of mostly white and European-born individuals. Similar studies are needed worldwide to inform public health recommendations for HIV-PrEP using populations, particularly in HTLV-endemic settings.

Original language	English
Pages (from-to)	245-247
Number of pages	3
Journal	Journal of Infection
Volume	86
Issue number	3
DOIs	https://doi.org/10.1016/j.jinf.2023.01.033
Publication status	Published - Mar 2023

Bibliographical note

Publisher Copyright:
© 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Bisexual and other men who have sex with men (GBMSM)
Gay
HIV pre-exposure prophylaxis
Human T cell lymphotropic virus type 1 (HTLV-1)

Access to Document

10.1016/j.jinf.2023.01.033

Cite this

Bradshaw, D., Khawar, A., Patel, P., Tosswill, J., Brown, C., Ogaz, D., Mason, E., Osman, R., Mitchell, H., Dosekun, O., Peris, B. M., Pickard, G., Rayment, M., Jones, R., Hopkins, M., Williams, A., Kingston, M., Machin, N., Taha, Y., ... Taylor, G. P. (2023). HTLV seroprevalence in people using HIV pre-exposure prophylaxis in England. Journal of Infection, 86(3), 245-247. https://doi.org/10.1016/j.jinf.2023.01.033

@article{cac3e677f9a04a70af0f1490fac19ec4,

title = "HTLV seroprevalence in people using HIV pre-exposure prophylaxis in England",

abstract = "Objectives: HTLV-1 is predominantly a sexually-transmitted infection but testing is not mentioned in HIV-PrEP guidelines. We ascertained HTLV-1/HTLV-2 seroprevalence amongst HIV-PrEP users in England. Methods: An unlinked anonymous seroprevalence study. Results: Amongst 2015 HIV-PrEP users, 95\% were men, 76\% of white ethnicity and 83\% had been born in Europe. There were no HTLV-1/HTLV-2 seropositive cases (95\% confidence interval 0\% – 0.18\%). Conclusions: There were no HTLV positive cases, likely reflecting the demographic of mostly white and European-born individuals. Similar studies are needed worldwide to inform public health recommendations for HIV-PrEP using populations, particularly in HTLV-endemic settings.",

keywords = "Bisexual and other men who have sex with men (GBMSM), Gay, HIV pre-exposure prophylaxis, Human T cell lymphotropic virus type 1 (HTLV-1)",

author = "Daniel Bradshaw and Arham Khawar and Poorvi Patel and Jennifer Tosswill and Colin Brown and Dana Ogaz and Emily Mason and Roeann Osman and Holly Mitchell and Olamide Dosekun and Peris, \{Borja Mora\} and Graham Pickard and Michael Rayment and Rachael Jones and Mark Hopkins and Andy Williams and Margaret Kingston and Nicholas Machin and Yusri Taha and Sarah Duncan and Neil Turner and Noel Gill and Nick Andrews and Mohammad Raza and Simon Tazzyman and Achyuta Nori and Emma Cunningham and Taylor, \{Graham P.\}",

note = "Publisher Copyright: {\textcopyright} 2023",

year = "2023",

month = mar,

doi = "10.1016/j.jinf.2023.01.033",

language = "English",

volume = "86",

pages = "245--247",

journal = "Journal of Infection",

issn = "0163-4453",

publisher = "W.B. Saunders Ltd",

number = "3",

}

Bradshaw, D, Khawar, A, Patel, P, Tosswill, J, Brown, C, Ogaz, D, Mason, E, Osman, R, Mitchell, H, Dosekun, O, Peris, BM, Pickard, G, Rayment, M, Jones, R, Hopkins, M, Williams, A, Kingston, M, Machin, N, Taha, Y, Duncan, S, Turner, N, Gill, N, Andrews, N, Raza, M, Tazzyman, S, Nori, A, Cunningham, E & Taylor, GP 2023, 'HTLV seroprevalence in people using HIV pre-exposure prophylaxis in England', Journal of Infection, vol. 86, no. 3, pp. 245-247. https://doi.org/10.1016/j.jinf.2023.01.033

TY - JOUR

T1 - HTLV seroprevalence in people using HIV pre-exposure prophylaxis in England

AU - Bradshaw, Daniel

AU - Khawar, Arham

AU - Patel, Poorvi

AU - Tosswill, Jennifer

AU - Brown, Colin

AU - Ogaz, Dana

AU - Mason, Emily

AU - Osman, Roeann

AU - Mitchell, Holly

AU - Dosekun, Olamide

AU - Peris, Borja Mora

AU - Pickard, Graham

AU - Rayment, Michael

AU - Jones, Rachael

AU - Hopkins, Mark

AU - Williams, Andy

AU - Kingston, Margaret

AU - Machin, Nicholas

AU - Taha, Yusri

AU - Duncan, Sarah

AU - Turner, Neil

AU - Gill, Noel

AU - Andrews, Nick

AU - Raza, Mohammad

AU - Tazzyman, Simon

AU - Nori, Achyuta

AU - Cunningham, Emma

AU - Taylor, Graham P.

PY - 2023/3

Y1 - 2023/3

N2 - Objectives: HTLV-1 is predominantly a sexually-transmitted infection but testing is not mentioned in HIV-PrEP guidelines. We ascertained HTLV-1/HTLV-2 seroprevalence amongst HIV-PrEP users in England. Methods: An unlinked anonymous seroprevalence study. Results: Amongst 2015 HIV-PrEP users, 95% were men, 76% of white ethnicity and 83% had been born in Europe. There were no HTLV-1/HTLV-2 seropositive cases (95% confidence interval 0% – 0.18%). Conclusions: There were no HTLV positive cases, likely reflecting the demographic of mostly white and European-born individuals. Similar studies are needed worldwide to inform public health recommendations for HIV-PrEP using populations, particularly in HTLV-endemic settings.

AB - Objectives: HTLV-1 is predominantly a sexually-transmitted infection but testing is not mentioned in HIV-PrEP guidelines. We ascertained HTLV-1/HTLV-2 seroprevalence amongst HIV-PrEP users in England. Methods: An unlinked anonymous seroprevalence study. Results: Amongst 2015 HIV-PrEP users, 95% were men, 76% of white ethnicity and 83% had been born in Europe. There were no HTLV-1/HTLV-2 seropositive cases (95% confidence interval 0% – 0.18%). Conclusions: There were no HTLV positive cases, likely reflecting the demographic of mostly white and European-born individuals. Similar studies are needed worldwide to inform public health recommendations for HIV-PrEP using populations, particularly in HTLV-endemic settings.

KW - Bisexual and other men who have sex with men (GBMSM)

KW - Gay

KW - HIV pre-exposure prophylaxis

KW - Human T cell lymphotropic virus type 1 (HTLV-1)

UR - https://www.scopus.com/pages/publications/85148339376

U2 - 10.1016/j.jinf.2023.01.033

DO - 10.1016/j.jinf.2023.01.033

M3 - Article

C2 - 36773896

AN - SCOPUS:85148339376

SN - 0163-4453

VL - 86

SP - 245

EP - 247

JO - Journal of Infection

JF - Journal of Infection

IS - 3

ER -

HTLV seroprevalence in people using HIV pre-exposure prophylaxis in England

Abstract

Bibliographical note

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this